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1. Background
Rotaviruses are globally the leading cause of severe
dehydrating diarrhea in children below 5 years of age.
According to WHO estimates, rotaviruses resulted in
approximately 453,000 (420,000-494,000) child
deaths in 2008 worldwide, mostly in low income coun-
tries (1). 
Rotaviruses belong to the genus Rotavirus in the
family of Reoviridae. Rotavirus virions are non-
enveloped forming an icosahedral triple-layered pro-
tein capsid the core of which carries the viral genome
consisting of 11 segments of double-stranded RNA
(dsRNA). The genome is surrounded by a triple-lay-
ered capsid and encodes six structural (VP1-VP4,
VP6, and VP7) and six nonstructural (NSP1-NSP6)
proteins. Nonstructural protein 4 (NSP4) is the entero-
toxin of this virus, which plays its role in the villus
epithelial cells and causes diarrhea (2). 
The non-structural protein 4 (NSP4) is a 175-
amino-acid enterotoxin with nascent polypeptide MW
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Background: Rotavirus group A (RVA) is recognized as a major cause of severe gastroenteritis in children and new-born
animals. Nonstructural protein 4 (NSP4) is responsible for the enterotoxic activity of these viruses in the villus epithelial
cells. Amino acids 114-135 of NSP4 are known to form the diarrhea-inducing region of this viral enterotoxin. Therefore,
developing an NSP4 lacking the enterotoxin domain could result in the introduction of a new subunit vaccine against
rotaviruses in both humans and animals. 
Objectives: The aim of this study is the evaluation of rotavirus A NSP4 expression in E. coli expression system before and
after removal of the diarrhea-inducing domain, which is the first step towards further immunological studies of the result-
ing protein. 
Materials and Methods: Splicing by overlap extension (SOEing) PCR was used to remove the diarrhea-inducing
sequence from the NSP4 cDNA. Both the full-length (FL-NSP4) and the spliced (S-NSP4) cDNA amplicons were cloned
into pET-32c and pGEX-6P-2. Expression levels of the recombinant proteins were evaluated in E. coli BL21 (DE3) by
Western blot analysis. In addition, the toxicity of pET plasmids bearing the S-NSP4 and FL-NSP4 fragments was investi-
gated by plasmid stability test.
Results: For FL-NSP4, protein expression was detected for the strain containing the pGEX:FL-NSP4 plasmid, but not for
the strain carrying pET:FL-NSP4. Hourly sampling up to 3 h showed that the protein production decreased by time. In con-
trast, expression of S-NSP4 was detected for pET:S-NSP4 strain, but not for pGEX:S-NSP4. Plasmid stability test showed
that pET:S-NSP4 recombinant plasmid was almost stable, while pET:FL-NSP4 was unstable.
Conclusions: This is the first report of production of rotavirus NSP4 lacking the diarrhea-inducing domain (S-NSP4). S-
NSP4 shows less toxicity in this expression system and potentially could be a promising goal for rotavirus immunologi-
cal and vaccine studies in the future.
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of approximately 20.2 kDa, which consists of distinct
domains that contribute to its multiple functions. The
domain functions include diarrhea-induction, which is
attributed to amino acids 114-135 in the cytoplasmic
tail, and calcium binding. A synthetic peptide corre-
sponding to the diarrhea-inducing domain, was shown
to induce diarrhea in neonatal mice in a 100-fold molar
excess in comparison to the full-length protein (3, 4).
However, this suggests that other domains could also
influence the diarrhea-induction ability of NSP4 (5).
This so-called diarrhea-inducing region forms part of
the oligomerization domain (amino acids 95-137), thus
contributes directly to the conformation of the func-
tional domain (C-terminus) of NSP4 (3, 6). It has also
been suggested that a unique conformation is required
for optimal function of rotavirus enterotoxin (7).
Moreover, the integrins α1β1 and α2β1 are receptors
for NSP4 in which amino acids 114-130 are responsi-
ble for binding to the I domain of α1; and residues
114-135 can block binding of the natural ligand, colla-
gen I, to Integrin α2 (8). This interaction in turn leads
to secretion of chloride ions and diarrhea-induction via
a phospholipase C (PLC) mediated pathway (9).
Therefore, it can be suggested that removing amino
acids 114-135 could effectively lower, if not inhibit,
the toxicity of NSP4 for two reasons: first, via disrupt-
ing the correct functional conformation and oligomer-
ization of the protein and second, via blocking the
interaction of NSP4 with integrin receptors.
Several studies have demonstrated successful
expression of this protein in eukaryotic cells such as
Sf9 cells of Spodoptera frugiperda (10-14). However,
expression of the full-length NSP4 in E. coli has been
a challenge thus far, due to its toxicity (15-17); while
there has been more success with truncated, modified,
or mutant NSP4 derivatives (5, 17-21). 
2. Objectives 
Here, the expression of the full-length and the
spliced forms of NSP4 (FL-NSP4 and S-NSP4, respec-
tively) of rotavirus A RF in E. coli BL21 (DE3) strain
carrying recombinant pGEX-6P-2 (pGEX:FL-NSP4)
and pET-32c (pET:S-NSP4) are presented.
Construction of S-NSP4 is reported for the first time
using splicing by overlap extension (SOEing) PCR
technique to delete the diarrhea-inducing domain. The
full length and the spliced fragments were cloned in
two E. coli expression systems and their expressions
were characterized by SDS-PAGE and Western blot
assays. The purpose of this study is to establish an
inexpensive, rapid, and uncomplicated method to pro-
duce both proteins for future studies on the structure,
function, and immunogenicity of rotavirus NSP4 and
its enterotoxin domain. This can be the first step
towards the introduction of a subunit rotavirus vac-
cine. 
3. Materials and Methods
3.1. Cell Culture and Virus
MA104 fetal Rhesus monkey kidney cells were
grown in Dulbeco’s modified Eagle medium (Gibco,
USA) containing 10% fetal bovine serum (Gibco,
USA), penicillin (Sigma-Aldrich, USA) (100 units.
mL-1), and streptomycin (Sigma-Aldrich, USA) (0.1
mg.mL-1) at 37°C and 5% CO2 (22, 23). After reach-
ing 50% of confluency, the MA104 cell cultures were
infected by rotavirus RF strain and incubated in serum-
free DMEM for 24 h (24, 25).
3.2. Primer Design and PCR Conditions
Total viral RNA was extracted with QIAzol lysis
reagent (Qiagen, Germany) according to manufactur-
er’s protocol, and total cDNA synthesis was carried
out by reverse transcription (RT-PDR) with random
hexamers. The complete coding DNA sequence of RF
rotavirus NSP4 mRNA (GenBank accession number
AY116593) was used to design two forward and two
reverse primers that amplified FL-NSP4 (535 bp) and
S-NSP4 (469 bp). To amplify FL-NSP4, the forward
primer F1 (5´-GTGCGGAAAGATGGAAAAGC) and the
reverse primer R2 (5´-CATCGCTGCAGTCACTTCTTT
TG) were used. However, in order to remove the diar-
rhea-inducing domain by SOEing PCR (26), the for-
ward primer F2 (5´-GAAATGATTATACGAGCAGTAG
AC) and the reverse primer R1 (5´-TGCTCGTATAATC
ATTTCTAGCTGACG) were also needed. Finally, two
primer pairs, F1-R1 and F2-R2 were used to amplify
the large (S1-NSP4) and the small (S2-NSP4) frag-
ments of S-NSP4, respectively. The large fragment
(358 bp) encodes amino acids 1-113 of NSP4, while
the small fragment (129 bp) encodes amino acids 136-
175. These two overlapping fragment were joined by
SOEing PCR in order to make S-NSP4 (Figure 1). All
PCR amplifications were carried out with Taq DNA
polymerase PCR kit (Thermo Scientific, USA) and the
reagents were used according to the manufacturer’s
protocol (for 50 μL reaction: 50-125 ng template
cDNA (RT-PCR product), 0.2 mM dNTP, 1X buffer,
1.5 mM MgCl2 , 4 U Taq polymerase, and 40 pmol of
each primer). To amplify FL-NSP4 and each of the two
S1- and S2-NSP4 fragments, the PCR was performed
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5 min at 95ºC (primary denaturation) followed by 35
cycles, each consisting of 95ºC for 1.5 min, 58ºC for 1
min and 72ºC for 1 min; and PCR was finalized at
72ºC for 10 min. The fragments were extracted from
agarose gel by HiYield Gel/PCR Fragments Extraction
Kit (RBC, Taiwan). S1-and S2-NSP4 were joined by
the SOEing PCR, which was performed using equimo-
lar amounts of the large and the small fragments as
template DNAs (50-150 ng of each per 50 μL reaction)
without adding any primers. The overlap extension
PCR was performed with these conditions: a pre-
denaturation at 95ºC for 5 min and 9 cycles of 95ºC for
1.5 min, 50ºC for 1.5 min, 72ºC for 80 s, and a final 5
min extension at 72ºC. The PCR was paused at 72ºC
and Taq polymerase (4 U per 50 μL reaction) was
added along with 40 pmol of the end primers i.e. F1
and R2, and the PCR was continued with 35 cycles of
95ºC for 1.5 min, 58ºC for 1 min, 72ºC for 1 min, and
a final extension at 72ºC for 5 min. In brief, the PCR
was performed in two consecutive steps: an overlap
extension and an amplification. The second step was
carried out in order to amplify the entire S-NSP4 that
had been produced in the first step (7). 
3.3. Plasmid Construction
FL- and S-NSP4 were primarily ligated into TA
cloning vector (RBC, Taiwan), according to manufac-
turer’s protocol, with T4 DNA ligase (Thermo
Scientific, USA) and were transformed into E. coli
DH5α competent cells (28). The cloning was con-
firmed by growth on LB agar (supplemented with 100
μg.mL-1 ampicillin) and, colony PCR. The plasmids
were isolated using GeneJET Plasmid Miniprep Kit
(Thermo Scientific, USA). Directions of the inserts
were confirmed by R-mapping using restriction
enzymes (HindIII and BamHI) and DNA sequencing.
The fragments were excised out of TA vector by EcoRI
and SalI. Each fragment was purified from agarose gel
and ligated into pET-32c(+) (Novagen, Germany) and
pGEX-6P-2 (GE healthcare Life Sciences) at
EcoRI/SalI sites with T4 DNA ligase. The new con-
structs were transformed into E. coli DH5α and final-
ly, the plasmids were extracted and transformed into E.
coli BL21 (DE3) competent cells. All constructs were
extracted from BL21 cells and were sequenced once
more for further confirmation.
3.4. Expression Conditions, SDS-PAGE and Western
Blotting
The four strains of E. coli BL21 (DE3) cells (each
containing either pET-32c or pGEX-6P-2 constructs of
FL- or S-NSP4) were used for protein expression.
Cells were cultured overnight in LB broth supplement-
ed with 100 μg.mL-1 ampicillin at 37°C in a shaking
incubator for 16 h. Cultures were diluted 1:100 into
fresh LB (containing 200 μg.mL-1 ampicillin and 1%
glucose) and grown to reach an OD600 of 0.5-0.7.
IPTG (1 mM) was added to induce protein expression
(29, 30). Samples were collected 30 min, 1 h, 2 h, and
3 h post-induction and centrifuged (HERMLE
Labortechnik Z 216 MK, Germany) for 10 min at 4°C
at 12,000 rpm. Pellets were re-suspended in lysis
buffer (8 M urea, 100 mM NaH2PO4, 10 mM Tris, 1%
SDS, and 1 mM EDTA) and sonicated at 100% ampli-
tude with a 2 mm probe for 4-6 cycles each consisting
of 5 s of sonication followed by 5 s intervals. Cell
lysates were again centrifuged and supernatants were
used for SDS-PAGE (10%). Western blot was carried
out on nitrocellulose membranes using rabbit anti-
NSP4 antiserum (kindly gifted by Dr. Lennart
Svensson, University of Linköping, Sweden) with a
dilution ratio of 1:250 and anti-His tag monoclonal
antibody (Roche, Germany) with a dilution ratio of
1:2000. Finally, 3,3´-Diaminobenzidine (DAB, Sigma
Aldrich, USA) was used to visualize the blots (16).
3.5. Plasmid Stability Test
This test was carried out and interpreted according
to pET System Manual (31). Briefly, cultures of the
strains carrying FL- and S-NSP4 in pET-32c were seri-
ally diluted in LB (without ampicillin) immediately
before induction. Each strain was plated at a dilution
of 10-5 on an LB agar plate containing both IPTG and
ampicillin, and an LB agar plate containing only IPTG.
They were also plated at a dilution of 10-6 on one LB
agar plate containing only ampicillin, and one LB agar
plate without any additives.
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Figure 1. The schematic diagram of the overlapping fragments of
S-NSP4. The first 18 nucleotides from the 5´ end (5´-3´) of F2 and
R1 are complementary. The first 9 nucleotides from the 5´ end of
F2 (5´-3´) are complementary to the last 9 nucleotides from the 3´
end (3´-5´) of the large fragment on the antisense strand, while the
first 9 nucleotides from the 5´end of R1 (5´-3´) are complementa-
ry to the first 9 nucleotides from the 5´ end (5´-3´) of the small
fragment on the sense strand. The hatched areas with the same pat-
tern have complementary sequences and each pattern represents 9
nucleotides
4. Results
4.1. Virus culture and SOEing PCR
MA104 cells were infected by bovine rotavirus RF
and cell lysates were gathered 24 h after infection. After
RNA extraction from the cell lysates, total cDNA was
synthesized. S1-NSP4 (358 bps) and S2-NSP4 (129 bps)
were amplified and joined by SOEing PCR. S-NSP4
fragment (469 bps) was generated and amplified. FL-
NSP4 was simply amplified from the cDNA (Figure 2).
4.2. Plasmid Construction
FL- and S-NSP4 were subcloned in both pGEX-6P-
2 and pET-32c after being cloned in TA cloning vector
(Figure 3). Among the sequenced TA:S-NSP4 sam-
ples, the sequence showed a single mutation, UUC to
UUU both coding for phenylalanine. Sequencing of S-
NSP4 in the expression vectors confirmed that it was
successfully subcloned without any further mutations.
The sequence of this S-NSP4 is available at GenBank
(accession number KM387404).
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Figure 2. Amplification of FL-NSP4, and S-NSP4 formed by the
overlap extension of the S1-NSP4 and S2-NSP4 fragments. A:
Lane 1: 1 kb ladder (Thermo Scientific, USA), lane 2: Negative
control, lane 3: FL-NSP4 (535 bp), lane 4: S1-NSP4 (358 bp) and
lane 5: S2-NSP4 (129 bp); B: Overlap extension amplification of
S-NSP4 (469 bp) (lane 2)
Figure 3. Schematic view of the four expression constructs developed in this study. A: pET:FL-NSP4; B:
pET:S-NSP4; C: pGEX:FL-NSP4; D: pGEX:S-NSP4. Maps created by SnapGene®
4.3. Production of FL- and S-NSP4 in E. coli BL21
(DE3)
Protein immunoblot assays using anti-NSP4 anti-
serum and anti-His tag monoclonal antibody showed
that only the pGEX:FL-NSP4 construct could produce
the full-length protein (Figure 4). In contrast, S-NSP4
was only detected for the strain containing pET:S-
NSP4 (Figure 5). The best condition for the expression
of FL-NSP4 in the pGEX plasmid was at 1 mM IPTG
and 1% glucose and 30 min after induction. For S-
NSP4 in pET-32c plasmid, the optimum expression
was obtained at 1 mM IPTG and 1% glucose 1 h after
induction. Longer incubation time for both showed
degradation of the proteins (Figures 4 and 5).
According to densitometry analyses (ImageJ 1.49v,
Wayne Rasband, NIH, USA), relative density for
pGEX:FL-NSP4 was 1, 0.4, 0.35, and 0.2 at 30 min, 1
h, 2 h, and 3 h after induction, respectively. Also, when
the anti-His antibody was used, relative density for
pET:S-NSP4 was 1, 1.2, 0.85, and 0.63 at 30 min, 1 h,
2 h and 3 h after induction, respectively. Almost the
same changes in relative density were observed when
anti-NSP4 anti-serum detected S-NSP4: 1, 1.2, 0.8 and
0.8 at 30 min, 1 h, 2 h, and 3 h after induction, respec-
tively.
4.4. Plasmid Stability
The cells carrying pET:FL-NSP4 formed 476 and
398 colonies on LB agar containing IPTG and LB agar
containing IPTG and ampicillin (both in dilution 10-5),
respectively. These cells formed 89 colonies on LB
agar and 58 colonies on LB agar containing ampicillin
(both in dilution 10-6). In contrast, cells carrying
pET:S-NSP4 formed 46 colonies on LB agar contain-
ing IPTG and no colonies on LB agar containing IPTG
and ampicillin (both in dilution 10-5). These cells
formed 56 colonies on LB agar and 50 colonies on LB
agar containing ampicillin (both in dilution 10-6)
(Table 1). 
5. Discussion
Human rotavirus A (HRV-A) has been identified as
the major causative agent of acute infantile gastroen-
teritis infecting newborns and children worldwide
(32). Due to the absence of efficient anti-rotavirus
drugs, efforts are being made to design vaccines to pre-
vent the disease (34). NSP4 can be used to generate
effective recombinant vaccines to hamper the effect of
HRV-A. Previous studies failed to express the full-
length NSP4 in E. coli using the pET expression sys-
Iran J Biotech. 2016;14(2):e123354
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Figure 4. Detection of FL-NSP4 expression. Lane 1, PageRulerTM
Prestained Protein Ladder (Thermo Scientific, USA);
Immunoblotting of MA104 lysates (lane 2, infected cells and lane
3, uninfected cells) and lysates of E. coli BL21 containing
pGEX:FL-NSP4 (lanes 4, 5, 6, and 7, correspond to 3 h, 2 h, 1h,
and 30 min post induction by IPTG, respectively; lane 8, unin-
duced). NSP4 was detected using anti-NSP4 antiserum. The
expected molecular weight was approximately 49 kDa because of
the presence of GST-tag. Faint bands with smaller molecular
weights probably correspond to degraded forms of the target pro-
tein. More than one bands were observed in MA104 cell lysates
probably corresponding to different glycosylation states of NSP4
Figure 5. Detection of S-NSP4 Expression. A: Western blots with
anti-His tag antibody: Lane 1, PageRulerTM Prestained Protein
Ladder (Thermo Scientific, USA); lysates of E. coli BL21 contain-
ing pET-32c (lane 2, uninduced; lane 3, 2 h post induction; lane 4,
3 h post induction) and lysates of E. coli BL21 containing pET:S-
NSP4 (lanes 5, 6, 7, 8, and 9 correspond to uninduced, 0.5, 1, 2,
and 3 h post induction by IPTG, respectively). B: Western blots
with anti-NSP4 antiserum: lysates of E. coli BL21 containing
pET:S-NSP4 (lanes 1, 2, 3, 4, and 5 correspond to uninduced, 0.5,
1, 2, and 3 h post induction by IPTG, respectively). C: Schematic
diagram of the expression units in pET-32c, pET:S-NSP4 and
pET:FL-NSP4
tem, but successful expression was reported for
Lactococcus lactis (16). The latter expression system
seems to be promising and can be used as an alterna-
tive expression system (34). Here, expression of the
rotavirus enterotoxin (NSP4) was carried out before
and after removal of its diarrhea-inducing domain in E.
coli BL21 DE3. As this protein is made of different
domains with distinct functions (3), it has been subject
of different studies in full-length, modified, truncated,
and mutated forms (5, 9, 17, 21). This protein is toxic
for both prokaryotic and eukaryotic (especially mam-
malian) cells because of disruption of calcium home-
ostasis and membrane destabilization (29, 35).
Successful expression of full-length NSP4 was report-
ed in Sf9 eukaryotic insect cells with higher tolerance
to the membrane destabilizing effect of the rotavirus
enterotoxin (11). Toxicity of NSP4 for E. coli has
already been observed (16), and is most probably
because of similarity of the bacterial inner membrane
to the membrane of the ER (15). Several studies have
demonstrated that NSP4 disrupts the integrity of the
ER membrane upon infection with rotavirus or expres-
sion of recombinant NSP4 in eukaryotic cells (11, 29,
35). Considering these facts, it is difficult to produce
the full-length NSP4 or its truncated domains in E.
coli, when they contain regions that contribute to cyto-
toxicity (15). 
In attempts made to express FL- and S- NSP4 in
pET-32c, no protein was produced for FL-NSP4.
Further, pGEX-6P-2 was used to seek for probable
expression. In total, four strains of E. coli BL21 (DE3)
containing recombinant plasmids of FL- or S-NSP4 in
both pET-32c and pGEX-6P-2 were prepared. Protein
expression was only detected in pGEX:FL-NSP4 and
pET:S-NSP4. The best expression results were
obtained by adding twice the initial concentration of
ampicillin (200 μg.mL-1 instead of 100 μg.mL-1) and
1% glucose to the culture medium. The logic behind
this condition was to impose a tighter selective force
on plasmid-carrying strains by using higher concentra-
tions of ampicillin, and to avoid leaky expression by
using glucose (30). 
According to the number of colony forming units
(CFUs) (Table 1), the proportion of the cells carrying
pET:S-NSP4 that formed colonies on LB agar plates
containing only IPTG to the number of the cells that
grew on LB agar alone was 46/560 (less than 2%).
Furthermore, the proportion of the same cells that
formed colonies on LB agar containing both IPTG and
antibiotic to the number of the cells that grew on LB
agar alone was 0/560 (less than 0.01%). Accordingly,
cells containing pET:S-NSP4 were stable.
Nevertheless, these proportions for pET:FL-NSP4
were 476/890 (more than 2%) and 398/890 (more than
0.01%), respectively, which show that the cells con-
taining pET:FL-NSP4 were unstable (27).
According to plasmid stability test, cells carrying the
pET:FL-NSP4 construct were unstable, which explains
the reason FL-NSP4 was not detected in Western blots.
These results are in accordance with the previous studies
which had reported unsuccessful expression of the same
protein using pET expression vectors (16). In contrast,
the pET:S-NSP4 recombinant plasmid was almost sta-
ble. The 41 kDa band that was observed for S-NSP4 was
weak in comparison to the control (pET plasmid alone)
in Western blots, probably due to the toxicity of S-NSP4.
A possible explanation could be that although the diar-
rhea-inducing domain (aa 114-135) was removed, still
the viroporin domain (aa 47-92) which includes the
membrane-destabalizing region (aa 55-69) was present
(3), and this may have lead to cytotoxicity. However, this
hypothesis, i.e. the cytotoxic effect of viroporin domain
alone even after removal of the diarrhea-inducing region,
has to be further investigated. FL-NSP4 was detected in
the pGEX:FL-NSP4 strain, and Western blot showed
that the amount of this 49 kDa protein decreased by time.
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Strain LB agar
(10-6)
LB agar+ampicillin
(10-6)
LB agar+IPTG
(10-5)
LB agar+IPTG+ampicillin
(10-5)
Test 1
pET:FL-NSP4
pET
Test 2
pET:S-NSP4
pET
89
613
56
630
58
538
50
618
476
38
46
44
398
0
0
0
Table 1. Plasmid stability test for pET:FL-NSP4 and pET:S-NSP4. The number of CFUs on different
plates. The test for each strain was carried out separately; and a strain containing pET-32c without any
inserts (empty pET) was used as a control each time
This decrease could have been resulted by the toxicity of
the protein, which was observed in previous studies
and/or degradation, which can be because of the release
of cellular proteases due to the membrane destabilizing
activity of NSP4. On the contrary, no track of S-NSP4
was detected in the pGEX:S-NSP4 strain cell lysates,
and this may be the result of higher toxicity level of the
resulting S:NSP4 fusion protein from pGEX as well as
protein degradation. Our hypothesis is that the interac-
tions between the protein fusion tags, constitutively
encoded by each plasmid, and these recombinant pro-
teins could cause conformational changes, which may
affect toxicity and stability of each fusion product.
Therefore, this may be another reason why each plasmid
could only express one of the two recombinant proteins
instead of both of them. 
6. Conclusions
Expression of NSP4 and its modified derivatives is
necessary for both structural-functional and immunologi-
cal studies; therefore, it is important to overcome hurdles
such as cytotoxicity to be able to produce decent amounts
of the desired proteins. This study was an effort to pro-
duce rotavirus NSP4 before and after removal of its diar-
rhea-inducing region in E. coli. We managed to produce
FL- and S-NSP4 in pGEX-6P-2 and pET-32c, respective-
ly. However, further studies are needed to optimize the
expression and to determine the folding, the functionali-
ty, and the toxicity of these proteins in different hosts and
in relation to different fusion tags. Therefore, fusion tags
should be considered and chosen carefully in expression
studies because they play an important role in the final
folding and thus the stability and function of any given
recombinant protein. Apart from the effect of fusion pro-
teins, the immunogenicity of NSP4 may be affected by
removal of its enterotoxin domain. This could also be
attributed to the function of this domain or the conforma-
tional changes that its removal imposes on the resulting
protein. No previous studies have reported the expression
of a modified version of NSP4 that lacks the diarrhea-
inducing region in E. coli. The structural, functional, and
immunological characteristics of the recombinant protein
that we expressed in this study is open to further investi-
gations.
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